Myasthenia Gravis Treatment Options
Kimberly Moran, PhD, MBA, Head of US Rare Diseases at UCB, discuses new treatment options for myasthenia gravis,
Kimberly Moran, PhD, MBA, Head of US Rare Diseases at UCB, discuses new treatment options for myasthenia gravis,
By Esteban Zapiain, advocate and blood cancer s urvivor | April 30, 2024 All patients deserve access to quality, affordable health plans. Fortunately, most insurance…
Maël Heiblig, MD, Hôpital Lyon Sud, Lyon, France, discusses the current treatment approaches for patients with VEXAS syndrome, which include controlling inflammation, controlling the clone,…
PHILADELPHIA (April 30, 2024) — On April 18, 2024, the White House Office of Science and Technology Policy (OSTP) hosted its inaugural White House Minority…
Abstract. Cancer and its treatment produce deleterious symptoms across the phases of care. Poorly controlled symptoms negatively affect quality of life and
Join fellow researchers, data scientists, and patient advocates in the quest to enhance today’s collection and exchange of standardized cancer data.
Overview The 12th Annual Symposium on Global Cancer Research (ASGCR) will be held virtually May 6 – May 9, 2024 [8AM-12PM Eastern Time each day]. See…
Cancer Discovery | 14 | 5 | May 2024
An abstract is unavailable.
Compared to chemotherapy alone, the addition of the EGFR-MET bispecific antibody significantly prolonged progression-free survival after subsequent therapy, said Dr. Ryan Gentzler during the European…
ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.